Childhood leukaemia is a disease that, when recognised early, has a significant impact on children’s quality of life and potential for recovery. The most common early symptoms include prolonged fatigue, reluctance to play, loss of appetite and paleness. In addition, easy bruising, bleeding gums, recurrent infections and pallor should also be noted. A paediatric-haemato-oncology specialist should be consulted when these symptoms interfere with daily activities or negatively affect the quality of life of the child. Early diagnosis is the most critical factor that directly increases the success of treatment and leukaemia can be suspected with a simple blood test, followed by detailed investigations and referrals.
Why are the symptoms of leukaemia so varied? Because leukaemia disrupts the production of blood cells by abnormal proliferation of stem cells in the bone marrow. This impairment affects the production of red blood cells, white blood cells and platelets, which can be accompanied by a wide range of symptoms such as fatigue, susceptibility to infections, abnormal bleeding and bruising. It is important for families to keep a close eye on any changes that become apparent and to seek medical advice if symptoms persist.
What do current blood tests show? A simple complete blood count (CBC) can reveal findings such as anaemia, thrombocytopenia or leukocyte changes. Suspicious results are confirmed by further tests to clarify the suspicion of leukaemia. Bone marrow biopsy and genetic/profile analyses play a critical role in this process, because the type of leukaemia and the behaviour of the disease are determined by these analyses and the treatment plan is shaped accordingly.
Modern Approaches and Promising Results in Treatment
Treatment success in childhood leukaemia depends on factors such as the type and stage of the disease and tolerability by the child. Currently, cellular targeted immunotherapy, smart drugs, highly accurate chemotherapy protocols and stem cell transplantation when necessary have significantly increased survival rates. This combined approach is the key to enhancing treatment, especially in the more leaky types of acute lymphoblastic leukaemia (ALL) and acute myelogenous leukaemia (AML).
Immunotherapy and targeted therapies offer the potential to specifically target cancer cells while minimising side effects. This allows children to return to their lives more quickly and safely, despite prolonged disease monitoring and the side effects of intensive chemotherapy. Stem cell transplantation is an important option that prevents the disease from returning in some high-risk cases and improves long-term survival. The treatment plan is personalised and meticulously managed by a multidisciplinary team.
The quality of life of children is preserved withearly diagnosis and approach to treatment. The treatment process is more effective with the active participation of families, lifestyle changes and highly compliant treatment follow-up. Long-term follow-up is critical to monitor the effects of chemotherapy and the rebuilding of the immune system.
Life-Saving Strategies for Families
The role of parents is crucial for early recognition of the disease. If a child shows symptoms such as prolonged fatigue, decreased desire to play, recurrent infections or bruising, immediate referral to a health facility is key to early diagnosis and successful treatment. Families should communicate openly with the healthcare team and contribute to the treatment process in a safe and harmonious manner. Considerations for the quality of life of children include a balanced diet, daily sleep patterns, infection prevention measures and psychological support. This holistic approach facilitates the treatment process and accelerates the healing process.
Social awareness and early screening programmes contribute to earlier diagnosis of leukaemia throughout the society. Healthcare organisations can create early awareness through information for families, symptom awareness and appropriate screening protocols. Thus, treatment initiation time is shortened and outcomes improve.
